Tie2-Dependent Neovascularization of the Ischemic Hindlimb Is Mediated by Angiopoietin-2

PLoS ONE - United States
doi 10.1371/journal.pone.0043568
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Potential Role of the Angiopoietin/Tie2 System in Ischemia-Induced Retinal Neovascularization

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2003English

Activation of Tie2 by Angiopoietin-1 and Angiopoietin-2 Results in Their Release and Receptor Internalization

Journal of Cell Science
Cell Biology
2006English

Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2017English

Polymerase -Interacting Protein 2 Promotes Postischemic Neovascularization of the Mouse Hindlimb

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2014English

Lipopolysaccharide (LPS)-mediated Angiopoietin-2-Dependent Autocrine Angiogenesis Is Regulated by NADPH Oxidase 2 (Nox2) in Human Pulmonary Microvascular Endothelial Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Abl Kinases Are Required for Vascular Function, Tie2 Expression, and Angiopoietin-1-Mediated Survival

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Angiopoietin/Tie2 Pathway Mediates Type 2 Diabetes Induced Vascular Damage After Cerebral Stroke

Neurobiology of Disease
Neurology
2011English

Increased Tie2 Expression, Enhanced Response to Angiopoietin-1, and Dysregulated Angiopoietin-2 Expression in Hemangioma-Derived Endothelial Cells

American Journal of Pathology
Forensic MedicinePathology
2001English

Angiotensin II Induces Expression of the Tie2 Receptor Ligand, Angiopoietin-2, in Bovine Retinal Endothelial Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy